Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?

Objective Acute myeloid leukaemia (AML) prognosis is enhanced with intensive remission induction chemotherapy (ICT) in eligible patients. However, ICT eligibility perceptions may differ among healthcare professionals. This nationwide, population-based study aimed to explore regional variation in ICT...

Full description

Saved in:
Bibliographic Details
Main Authors: Hester F Lingsma, David van Klaveren, Arjan A van de Loosdrecht, Anna van Rhenen, Otto Visser, Valery E P P Lemmens, Nikki van Leeuwen, Gerwin Huls, Z L Rana Kaplan, Eduardus F M Posthuma, Danielle van Lammeren-Venema, Tjeerd J F Snijders, Catharina H M J van Elssen, Peter A von dem Borne, Nicole M A Blijlevens, Jan J Cornelissen, Marc H G P Raaijmakers, Avinash G Dinmohamed
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/3/1/e000264.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjoncology.bmj.com/content/3/1/e000264.full

Similar Items